# HKSH Medical Group Strengthens Collaboration with United Imaging

- Link: https://www.thailand-business-news.com/pr-news/hksh-medical-group-strengthens-collaboration-with-united-imaging
- Published: 2026-09-23T16:50:00+07:00
- Author: Media OutReach

#### _Introducing Hong Kong’s First Total-Body PET/CT System to Strengthen “Dual-Tracer” in Nuclear Medicine and Advance Innovation in Cancer Theranostics_

HONG KONG SAR – [Media OutReach Newswire](https://www.media-outreach.com/) – 23 
September 2026 – HKSH Medical Group (HKSH) has long been committed to advancing 
precision medicine. In the field of cancer diagnosis, HKSH actively introduces innovative
technologies and promotes clinical research to support the most accurate clinical
diagnosis and treatment planning, where nuclear medicine is an indispensable medical
specialty in modern cancer diagnosis and treatment. To further expand its technological
capabilities, HKSH Cancer Centre has introduced Hong Kong’s first long axial total-
body PET/CT system, developed by United Imaging Healthcare (United Imaging). The
system enables highly sensitive whole-body dynamic imaging combining low radiation
exposure, efficiency and high precision. In a single imaging examination, it can
accurately track small early-stage cancer lesions and hidden metastatic cancer cells
throughout the body, significantly enhancing diagnostic effectiveness and helping
physicians formulate targeted precision treatment plans.

![Mr. Wyman LI, Governor of The Li Shu Fan Medical Foundation, Chief Operating Officer
of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital (2nd left),
Mr. BAO Jun, President of United Imaging Healthcare (2nd right), Mr. XIA Jusong,
President of International Business at United Imaging Healthcare (right), and Dr.
Garrett HO, Head of Department of Nuclear Medicine and PET at HKSH (left), officiated
at the launch ceremony of Hong Kong's first total-body PET/CT system.](https://images.
media-outreach.com/release.php/Thumb/1600x1067/814655/814655-Photo-jpg-1600x1067.
jpeg)

 _Mr. Wyman LI, Governor of The Li Shu Fan Medical Foundation, Chief Operating Officer
of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital (2nd left),
Mr. BAO Jun, President of United Imaging Healthcare (2nd right), Mr. XIA Jusong,
President of International Business at United Imaging Healthcare (right), and Dr.
Garrett HO, Head of Department of Nuclear Medicine and PET at HKSH (left), officiated
at the launch ceremony of Hong Kong’s first total-body PET/CT system._

 **Mr. Wyman LI, Governor of The Li Shu Fan Medical Foundation, Chief Operating 
Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital, Mr.
BAO Jun, President of United Imaging Healthcare, Mr. XIA Jusong, President of International
Business at United Imaging Healthcare, and Dr. Garrett HO, Head of Department of
Nuclear Medicine and PET at HKSH**, officiated today at the launch ceremony for 
Hong Kong’s first long-axial total-body PET/CT system. The ceremony marks the strengthened
collaboration between HKSH and United Imaging, further advancing innovation in medical
imaging technology and the development of higher clinical diagnostic standards across
Greater China.

 **Mr. Wyman LI, Governor of The Li Shu Fan Medical Foundation, Chief Operating 
Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital,**
said, “Precision cancer care is at the core of HKSH’s development, while advanced
diagnostic imaging is an indispensable component of precision medicine. HKSH established
Asia’s first clinical PET centre in 1999. Today, HKSH operates 5 medical cyclotrons
and 3 radiopharmacy laboratories capable of producing more than 30 types of positron-
emitting tracers and isotope-based medicines, making it one of the few cancer centres
in the region with comprehensive nuclear medicine services.”

 With high expectations for the collaboration between HKSH and United Imaging in
advancing nuclear medicine imaging, **Mr. Wyman LI** added, “Last year, HKSH and
United Imaging entered into a strategic collaboration, through which HKSH helps 
optimise the application of United Imaging’s CT systems with its extensive clinical
experience. This year, we are deepening our collaboration by introducing Hong Kong’s
first total-body PET/CT system. The system overcomes the limitations of conventional
scanning and helps detect early and hidden cancer lesions. This new generation of
PET/CT scanners enable further integration of HKSH’s extensive clinical experience
with United Imaging’s advanced research and development capabilities. Together, 
we aim to provide safer, more efficient and personalised cancer diagnosis and treatment
for patients in Hong Kong and the Greater Bay Area. Looking ahead, we will continue
to promote innovation in medical imaging and establish new standards for precision
medicine.”

 **Mr. Jun BAO, President of United Imaging Healthcare, said, **“United Imaging 
has always believed that the value of medical imaging innovation lies in addressing
real clinical needs and creating meaningful value for patients. Looking ahead, we
look forward to working with HKSH to bring advanced molecular imaging technologies
to more patients in Hong Kong.”

 The United Imaging uMI Panorama GS total-body PET/CT system’s most significant 
breakthrough is its 148-centimetre ultra-long axial field of view. It enables the
brain, heart, lungs, liver and other major organs to be imaged simultaneously in
a single scan, overcoming the limitations of conventional PET systems, which generally
provide a local scanning range of only 15 to 30 centimetres.

 A single imaging examination can capture near-full-body images seamlessly, eliminating
the need for patients to undergo multiple local scans and subsequent image stitching
to track hidden metastatic lesions. The expanded detection range increases system
sensitivity by up to 25 times. Its enhanced photon-detection capability allows the
dose of injected tracer to be reduced, significantly lowering radiation exposure
and providing a safer imaging exam option for radiation-sensitive patients, including
paediatric patients. At the same time, high-definition dynamic imaging enables clinical
teams to monitor tracer distribution, uptake and metabolic trajectory in real time.
Combined with artificial intelligence-based denoising technology, the system further
enhances cancer diagnostic performance. All these advantages together with much 
improved electronics and algorithms contribute to the capability of tracer dynamic
studies. The addition of a time variable can resolve different phases of tracer 
interaction with the target organ or tumours.

 **Mr. Jusong XIA, President of International Business at United Imaging Healthcare,
said, **“Working with leading healthcare institutions around the world is an important
part of United Imaging’s international development. The introduction of Hong Kong’s
first long-axial PET/CT at HKSH reflects the deep integration of United Imaging’s
technological innovation with Hong Kong’s clinical expertise, and demonstrates how
advanced imaging technologies can be better integrated into different healthcare
systems and clinical practice.”

 **Advanced Hardware Combined with “Dual-Tracer Tracking” Reveals the Full Picture
of Cancer**

 Accurate identification of cancer cells requires a high degree of integration of
hardware and radiotracers. Although total-body PET/CT offers powerful detection 
capabilities, tracers are essential for guiding the imaging process. Conventional
examinations may have limitations because different types of cancer cells at different
stages have significantly different metabolic and receptor characteristics. As a
result, using a single tracer may not reveal the full picture of cancerous lesions.
In particular, some early-stage cancer cells may show limited uptake of conventional
tracers, leading to less comprehensive examination results.

 HKSH’s Department of Nuclear Medicine and PET is Asia’s first clinical PET centre
with onsite cyclotron and radiopharmacy laboratory to produce radiotracers. **Head
of the Department Dr. Garrett HO**, said, “HKSH’s nuclear medicine services are 
patient-centred. Our team has long established a clinical standard based on ‘dual-
tracer tracking’. HKSH was the world’s first medical institute to use the complementary
tracers of ¹¹C-acetate and ^(18)F-FDG to overcome the diagnostic challenge of low
glucose uptake in early-stage hepatocellular carcinoma^(1), renal cell carcinoma
^(2) and myeloma^(3,4). This enables effective detection of cancer cells from the
early stage through to the intermediate and advanced stages. Today, our centre offers
a range of tracers targeting the characteristics of different tumours. Combined 
with advanced imaging equipment, these technologies can clearly capture the full
picture in a single imaging examination, whether it involves tiny early-stage primary
lesions or hidden metastatic cancer cells throughout the body. This provides an 
important basis for clinicians to formulate precision treatment plans.”

 The launch of total-body PET/CT system is expected to further advance nuclear medicine
technology in Hong Kong and the Greater Bay Area. It also marks a new milestone 
in the collaboration between HKSH and United Imaging, building on a strong foundation
of cooperation. Looking ahead, HKSH will continue to play a leading role by combining
the strengths of both parties to provide patients with more accurate and efficient
cancer diagnosis.

 _1. Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma
and other liver masses. J Nucl Med. 2003;44(2):213-221._ 
 _2._ _Ho CL, Chen S, 
Ho KM, et al. Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell
carcinoma. Clin Nucl Med. 2012;37(11):1075-1082._  _3._ _Ho CL, Chen S, Cheng T,
Leung YL, Wong KK. Preliminary assessment of 11C-acetate and 18F-FDG PET/CT for 
the diagnosis and management of multiple myeloma. J Nucl Med. 2011;52(suppl 1):369._
_4. Ho CL, Chen S, Leung YL, et al. 11C-acetate PET/CT for metabolic characterization
of multiple myeloma: a comparative study with 18F-FDG PET/CT. J Nucl Med. 2014;55(
5):749-752._

Hashtag: #HKSH

The issuer is solely responsible for the content of this announcement.

#### About HKSH Medical Group

Officially launched in September 2017, HKSH Medical Group promotes public health
and advanced medicine through a multi-faceted, coordinated approach across clinical
services, medical education, scientific research and public health education. Members
of the Group, including Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern
Medical Centre, HKSH Cancer Centre and HKSH Institute for Innovation & Professional
Development, are dedicated to offering top-quality holistic care to patients.

 Established in 1922, Hong Kong Sanatorium & Hospital is one of the key members 
of HKSH Medical Group and a leading private hospital in Hong Kong. Living up to 
its motto of ‘Quality in Service, Excellence in Care’, the Hospital is committed
to serving the public as well as promoting medical education and research.

 For more information about HKSH Medical Group, please visit [http://www.hksh.com](http://www.hksh.com).

![](//track.media-outreach.com/index.php/WebView/489659/36955)

**Source** : [HKSH Medical Group Strengthens Collaboration with United Imaging](https://www.media-outreach.com/news/hong-kong-sar/2026/09/23/489659/?rand=186006)

---

  |  This article was produced by Media OutReach, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not reflect the opinions of Thailand Business News. |

---

![Media OutReach Newswire](https://i0.wp.com/www.thailand-business-news.com/wp-content/
uploads/2025/04/media-outreach-20025.png?ssl=1)